Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil

There are about 350 million hepatitis B virus (HBV) carriers worldwide and chronic HBV is considered a major public health problem. The objective of the present study was to assess the effectiveness of the nucleos(t)ide analogues tenofovir (TDF) and entecavir (ETV) in the treatment of chronic HBV. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Camila V, Tovo, Cristiane Valle, Grossmann, Thiago K, Mirenda, Henrique, Dal-Pupo, Bruna B, de Almeida, Paulo RL, de Mattos, Angelo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830114/
https://www.ncbi.nlm.nih.gov/pubmed/27074254
http://dx.doi.org/10.1590/0074-02760150390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830114/
https://www.ncbi.nlm.nih.gov/pubmed/27074254
http://dx.doi.org/10.1590/0074-02760150390

Ejemplares similares